Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China

Trial Identifier: MEQ00076
Sponsor: Sanofi
Start Date: September 2025
Primary Completion Date: January 2026
Study Completion Date: June 2026
Condition: Immune, Inflammatory & Infections - Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CHINA LIUZHOU, CHINA, 545100
CHINA, Guangxi Nanning, Guangxi, CHINA, 530028